Regency Fincorp board to meet Oct 16 for ESOPs and preferential issue
- Board meeting scheduled for October 16, 2026
- Agenda includes ESOP issuance and preferential issue of securities
- Proposal to increase authorised share capital
- Notice for Extraordinary General Meeting to be approved

*this image is generated using AI for illustrative purposes only.
Regency Fincorp Limited scheduled a Board of Directors meeting for Friday, October 16, 2026. The agenda includes approving the issuance of Employee Stock Options (ESOPs) and the allotment of securities on a preferential basis.
The company informed BSE Limited that the meeting will also consider an increase in the authorised share capital. Additionally, the Board will approve the notice for an Extraordinary General Meeting (EGM) related to these fund-raising activities.
Agenda highlights
The Board's agenda focuses on capital structure adjustments and employee incentive plans:
- ESOP Issuance: Approval for issuing Employee Stock Options to eligible employees, subject to applicable laws and regulations.
- Preferential Issue: Consideration of the issue and allotment of securities on a preferential basis.
- Capital Increase: Approval for increasing the authorised share capital of the company.
- EGM Notice: Approval of the notice for the Extraordinary General Meeting to ratify these actions.
Regulatory compliance
The intimation was filed under Regulation 29 of Chapter IV and Regulation 50 of Chapter V of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was signed by Abhimanyu, Company Secretary & Compliance Officer.
Historical Stock Returns for Regency Fincorp
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.01% | +7.01% | +17.43% | +94.91% | +43.98% | +929.92% |
Who are the identified anchor investors for the preferential allotment, and what premium or discount to market price is expected?
How will the proposed increase in authorised share capital impact existing shareholders' equity dilution upon full conversion of ESOPs and new securities?
What specific growth initiatives or debt reduction plans are intended to be funded by the capital raised through these instruments?

































